Sprout Pharmaceuticals' Series A - II Round

Sprout Pharmaceuticals raised a round of funding on July 11, 2012.

Sprout Pharmaceuticals is focused on the commercialization of products that address unmet medical needs in the field of female sexual health. Sprout Pharmaceuticals has acquired flibanserin, a central…

Articles about Sprout Pharmaceuticals' Series A - II Round: